These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4125143)

  • 1. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 2. An immunological evaluation of pleural effusions in systemic lupus erythematosus.
    Small P; Frank H; Kreisman H; Wolkove N
    Ann Allergy; 1982 Aug; 49(2):101-3. PubMed ID: 7103145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic studies in patients with systemic lupus erythematosus.
    Forman MD; Kaplan D
    Prim Care; 1978 Mar; 5(1):133-42. PubMed ID: 77535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lupus nephritis: clinico-immunological correlations based on studies of the complement system, fibrinogen (fibrin) degradation products and PHA-induced lymphocyte transformation].
    Szewczyk Z; Klinger M; Górecka Z; Ratajczak T; Melcer H
    Pol Arch Med Wewn; 1976 Nov; 56(5):419-31. PubMed ID: 1005168
    [No Abstract]   [Full Text] [Related]  

  • 8. Lupus nephritis: long-term follow-up.
    Cameron JS; Jones MB
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1187-91. PubMed ID: 4215066
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
    Via CS; Allen RC; Welton RC
    J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus nephritis: immunofluorescence study of 54 cases.
    Morel-Maroger L; Méry JP; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1183-6. PubMed ID: 4610502
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 12. Rheumatoid arthritis and systemic lupus erythematosus (SLE).
    Beer TC; Gumpel JM
    Proc R Soc Med; 1973 Sep; 66(9):910. PubMed ID: 4141773
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 14. Lupus-erythematosus-like syndrome with a familial defect of complement.
    Moncada B; Day NK; Good RA; Windhorst DB
    N Engl J Med; 1972 Mar; 286(13):689-93. PubMed ID: 4110615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lupus pericarditis: immunopathogenetic aspects and clinico-diagnostic findings].
    Avallone A; Pacilli S; Balderi C; Pompei V; Antonini VE; Vittore F
    Cardiologia; 1982; 27(3):251-9. PubMed ID: 6205667
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum complement in systemic lupus erythematosus (SLE).
    Asano S; Marumo K; Igaki Y; Toyoizumi E; Okubo M
    Arerugi; 1968 Jul; 17(7):597-609. PubMed ID: 5726584
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephropathy in the prognosis of systemic lupus erythematosus].
    Zanetti NL; Fernández AE; Spresi FN; Marini A; Juárez Peñalva H; Capdevila A
    Medicina (B Aires); 1982; 42(2):127-35. PubMed ID: 6983021
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of serum complement in the hypocomplementaemic nephritides.
    Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
    Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural effusion in systemic lupus erythematosus.
    Reda MG; Baigelman W
    Acta Cytol; 1980; 24(6):553-7. PubMed ID: 6160709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.